DAVID KELLER: Open Payments
NPI 1124192406 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 50 payments from 19 companies in 2025. Trend: 2023 $800 · 2024 $1,102 · 2025 $1,050
Food & beverage: $970Education: $80
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 4 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $153 |
| Novo Nordisk Inc | 5 | $104 |
| PFIZER INC. | 4 | $90 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| Abbott Laboratories | 3 | $70 |
| BridgeBio Pharma, Inc. | 4 | $65 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Baxter Healthcare | 2 | $36 |
Products named: OPSUMIT, Wegovy, Kerendia, VYNDAQEL, CARDIOMEMS, Attruby, LifeVest, OPSYNVI.
Industry payments across NC — which companies pay providers there.
